Comparison of clinical features in FMF patients according to severity scores: An analysis with the ISSF scoring

N Şule Yaşar Bilge1, Erdal Bodakçi1, Muzaffer Bilgin2

  • 1Division of Rheumatology, Department of Internal Medicine, Eskişehir Osmangazi University, Eskişehir, Turkey.

Abstract

Insights

Familial Mediterranean fever (FMF) patients with early onset and diagnosis show more severe disease, indicated by pleuritis, arthritis, and myalgia. Monitoring these individuals can prevent complications like amyloidosis and chronic kidney disease.

Area of Science:

  • Rheumatology
  • Genetics
  • Internal Medicine

Background:

  • Familial Mediterranean fever (FMF) is a chronic autoinflammatory disorder.
  • Characterized by recurrent episodes of fever and serositis.
  • Predicting FMF disease severity remains challenging.

Purpose of the Study:

  • To identify factors influencing disease severity in Familial Mediterranean fever.
  • To evaluate the correlation between clinical manifestations and disease severity using the ISSF score.

Main Methods:

  • Retrospective analysis of medical data from 150 FMF patients.
  • Utilized the International severity scoring system for Familial Mediterranean fever (ISSF) to categorize severity.
  • Grouped patients into mild (ISSF ≤2), moderate (ISSF 3-5), and severe (ISSF ≥6) categories.

Main Results:

  • Younger age at disease onset and diagnosis correlated with increased FMF severity.
  • Severe FMF cases exhibited higher prevalence of pleuritis, erysipelas-like erythema (ELE), arthritis, and myalgia.
  • Fever, peritonitis, and vasculitis were similarly distributed across severity groups.

Conclusions:

  • Early onset and diagnosis in FMF patients are associated with more severe disease phenotypes.
  • Increased monitoring of FMF patients with early onset/diagnosis is crucial.
  • Proactive management may mitigate risks of amyloidosis and chronic kidney disease, improving long-term outcomes.